Actionnariat et activité des initiés pour Cellectar Biosciences, Inc. (CLRB): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $2.35 |
| Capitalisation | $19M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-07-08 | Loren Stefan | A-Award | 15,000 | $40K |
| 2026-07-07 | Kolean Chad J | A-Award | 92,000 | $289K |
| 2026-07-07 | DRISCOLL FREDERICK W | A-Award | 25,000 | $68K |
| 2026-07-07 | Chanan-Khan Asher | A-Award | 25,000 | $68K |
| 2026-07-07 | CARUSO JAMES V | A-Award | 250,000 | $785K |
| 2026-07-07 | Gu Andrew | A-Award | 25,000 | $68K |
| 2026-07-07 | Longcor Jarrod | A-Award | 118,000 | $371K |
| 2026-07-07 | Swirsky Douglas J | A-Award | 37,500 | $101K |
| 2026-07-07 | NEIS JOHN | A-Award | 25,000 | $68K |
| 2026-07-08 | Loren Stefan | A-Award | 15,000 | $40K |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $11.4M | $10.0M | $13.3M | $10.6M | $57.2M | $35.7M | $19.9M | $9.6M | $23.3M | $13.2M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Créances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $12.2M | $10.5M | $14.0M | $11.4M | $57.9M | $36.6M | $20.5M | $10.5M | $24.3M | $14.0M |
| Immobilisations Corporelles | $1.4M | $244713 | $543339 | $783924 | $638347 | $549135 | $978975 | $1.6M | $1.2M | $910076 |
| Goodwill | $1.7M | $1.7M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $15.3M | $12.9M | $15.1M | $12.3M | $58.7M | $37.2M | $21.6M | $12.1M | $25.5M | $15.0M |
| Dettes Fournisseurs | $1.4M | $1.9M | $1.5M | $1.3M | $1.4M | $1.4M | $2.6M | $5.6M | $4.1M | $1.4M |
| Dette à Court Terme | $86591 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $1.6M | $2.1M | $1.6M | $2.8M | $3.6M | $4.0M | $11.5M | $25.4M | $9.4M | $4.7M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $1.8M | $2.1M | $1.8M | $3.2M | $3.9M | $4.2M | $12.1M | $25.9M | $11.2M | $5.1M |
| Réserves | -$70.8M | -$84.3M | -$97.6M | -$111.7M | -$126.8M | -$150.9M | -$160.0M | -$202.8M | -$247.3M | -$269.1M |
| Capitaux Propres | $13.5M | $10.8M | $13.3M | $9.1M | $54.8M | $33.0M | $9.5M | -$13.8M | $14.3M | $9.9M |
| Dette Totale | $94567 | $5249 | $2213 | $527529 | $421644 | $301741 | $603828 | $552982 | $494003 | $409586 |
| Dette Nette | -$11.4M | -$10.0M | -$13.3M | -$10.1M | -$56.7M | -$35.4M | -$19.3M | -$9.0M | -$22.8M | -$12.8M |
| Fonds de Roulement | $10.6M | $8.4M | $12.3M | $8.6M | $54.4M | $32.6M | $9.0M | -$14.9M | $14.9M | $9.3M |
Santé financière
| Dette / Capitaux propres | 0.05 |
| Ratio de liquidité | 6.66 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -28.56 |
Rentabilité
| Rentabilité des capitaux propres | -165.71% |
| Rentabilité du capital investi | -74.93% |
| Rentabilité des actifs | -60.93% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: AEON · BOLT · CING · EVGN · IMNN · LYRA · MBIO
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de CLRB: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions